Targeting the histone‐fold dimerization interface of oocyst rupture proteins from Plasmodium berghei for antimalarial inhibitor discovery
The FEBS Journal · 2026
DOI: 10.1111/febs.70389 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2026. Verfasst von Federico Ballabio und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, University of Milano, Italy. Hauptthemen laut MEDLINE: Plasmodium berghei, Histones, Oocysts, Protozoan Proteins. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Ministero dell'Università e della Ricerca, H2020 Future and Emerging Technologies, Hellenic Foundation for Research and Innovation.
Abstract (Originalsprache)
Dimerization between the histone‐fold domains (HFD) of two Plasmodium Oocyst Rupture Proteins (ORP1 and ORP2) is essential for oocyst rupture in the Anopheles mosquito vector host, representing a key event in parasite transmission to humans. Notably, ORPs are a rare example of HFD‐containing proteins that operate outside the nucleus and that lack DNA‐binding functions, typically associated with core histones and transcription factors hosting deviant histones. ORP HFD heterodimerization occurs at the outer capsule of the oocyst, immediately prior to rupture, thus providing a temporal window to administer dimerization blocking molecules. In this context, we present the first detailed structural analysis of the HFD ORP heterodimer, solved by X‐ray crystallography at 3.1 Å resolution, and analyze the oligomerization interface as a possible druggable target. Targeting the mosquito phase of the parasite lifecycle remains an under‐exploited avenue as present antimalarial therapies mainly target the human blood stages of infection. We employed a GAL4‐based yeast two‐hybrid (Y2H) combinatorial library of cyclic peptides (CPs) to identify six candidates that inhibit dimerization in vitro . Molecular docking simulations confirmed that all six CPs bind at the dimer interface, allowing us to rank them for further in vivo testing of their efficacy in blocking oocyst rupture.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences, University of Milano, Italy.
- National Research Council of Italy, Biophysics Institute (CNR-IBF), Milan, Italy.
- Department of Pathophysiology and Transplantation, L.I.T.A. Segrate, Italy.
- Foundation for Research and Technology Hellas, Institute of Molecular biology and Biotechnology, Heraklion, Crete, Greece.
- Department of Biology, Voutes University Campus, University of Crete, Heraklion, Crete, Greece.
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
ORCID-Profile: Federico Ballabio, Simona Masiero, Marco Nardini, Louise J Gourlay
Förderung
- Ministero dell'Università e della Ricerca
- H2020 Future and Emerging Technologies
- Hellenic Foundation for Research and Innovation
Zitieren
APA
Ballabio, F., Bertaso, C., Villa, M., Livero, O., Del Cont Bernard, A., Russo, R., Gessmann, R., Siden-Kiamos, I., Preira, C. M. F., Kumawat, A., Gabrieli, P., Camilloni, C., Currà, C., Masiero, S., Nardini, M., & Gourlay, L. J. (2026). Targeting the histone‐fold dimerization interface of oocyst rupture proteins from Plasmodium berghei for antimalarial inhibitor discovery. The FEBS Journal. https://doi.org/10.1111/febs.70389
Vancouver
Ballabio F, Bertaso C, Villa M, Livero O, Del Cont Bernard A, Russo R, et al. Targeting the histone‐fold dimerization interface of oocyst rupture proteins from Plasmodium berghei for antimalarial inhibitor discovery. The FEBS Journal. 2026. doi:10.1111/febs.70389
BibTeX
@article{Ballabio2026,
author = {Ballabio, Federico and Bertaso, Chiara and Villa, Marta and Livero, Ophelia and Del Cont Bernard, Alessandro and Russo, Rosaria and Gessmann, Renate and Siden-Kiamos, Inga and Preira, Claude Marie Francois and Kumawat, Amit and Gabrieli, Paolo and Camilloni, Carlo and Currà, Chiara and Masiero, Simona and Nardini, Marco and Gourlay, Louise J},
title = {Targeting the histone‐fold dimerization interface of oocyst rupture proteins from Plasmodium berghei for antimalarial inhibitor discovery},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70389}
}
EUVIMED